Engineering exosomes as nanocarriers traverse the blood-brain barrier for theranostics against glioblastoma: Opportunities and challenges
Authors:
- Chang LiCLChang Li
- Mohammad Javad AfshariMAMohammad Javad Afshari
- Jun LiuJLJun Liu
Open Access
- 1 June 2023
- journal article
- editorial
- Published by KEAI Publishing in Meta-Radiology
- Vol. 1 (1)
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (61971451)
- Science and Technology Program of Hunan Province (2021RC4016)
This publication has 20 references indexed in Scilit:
- Strategies for delivering therapeutics across the blood–brain barrierNature Reviews Drug Discovery, 2021
- The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implicationsCellular & Molecular Immunology, 2020
- The biology , function , and biomedical applications of exosomesScience, 2020
- Extracellular vesicles as drug delivery systems: Why and how?Advanced Drug Delivery Reviews, 2020
- The blood-brain barrier: Physiology and strategies for drug deliveryAdvanced Drug Delivery Reviews, 2020
- Mechanisms of immunotherapy resistance: lessons from glioblastomaNature Immunology, 2019
- Delivery technologies for cancer immunotherapyNature Reviews Drug Discovery, 2019
- Current state of immunotherapy for glioblastomaNature Reviews Clinical Oncology, 2018
- In Vivo Neuroimaging of Exosomes Using Gold NanoparticlesACS Nano, 2017
- Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targetingJournal of Extracellular Vesicles, 2015